TY  - GEN
AU  - Bryce,Alan H
AU  - Borad,Mitesh J
AU  - Egan,Jan B
AU  - Condjella,Rachel M
AU  - Liang,Winnie S
AU  - Fonseca,Rafael
AU  - McCullough,Ann E
AU  - Hunt,Katherine S
AU  - Ritacca,Nicole R
AU  - Barrett,Michael T
AU  - Patel,Maitray D
AU  - Young,Scott W
AU  - Silva,Alvin C
AU  - Ho,Thai H
AU  - Halfdanarson,Thorvardur R
AU  - Stanton,Melissa L
AU  - Cheville,John
AU  - Swanson,Scott
AU  - Schneider,Daniel E
AU  - McWilliams,Robert R
AU  - Baker,Angela
AU  - Aldrich,Jessica
AU  - Kurdoglu,Ahmet
AU  - Izatt,Tyler
AU  - Christoforides,Alexis
AU  - Cherni,Irene
AU  - Nasser,Sara
AU  - Reiman,Rebecca
AU  - Cuyugan,Lori
AU  - McDonald,Jacquelyn
AU  - Adkins,Jonathan
AU  - Mastrian,Stephen D
AU  - Von Hoff,Daniel D
AU  - Craig,David W
AU  - Stewart,A Keith
AU  - Carpten,John D
TI  - Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib
SN  - 1938-0682
PY  - 2018///0925
KW  - Adenocarcinoma, Mucinous
KW  - drug therapy
KW  - Aged
KW  - ErbB Receptors
KW  - genetics
KW  - Erlotinib Hydrochloride
KW  - administration & dosage
KW  - Gene Amplification
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Male
KW  - Neoplasm Metastasis
KW  - Precision Medicine
KW  - Sequence Analysis, DNA
KW  - methods
KW  - Up-Regulation
KW  - Urethral Neoplasms
N1  - Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clgc.2016.11.001
ER  -